跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mupicent - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mupicent
Approved
STANDARD
Mupicent
Scott-Edil Pharmacia Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d0c49266ef499f88
Company
Scott-Edil Pharmacia Ltd.
Type
Standard
Approval Details
Approval Id
d0c49266ef499f88
Drug Approval Philippines Name
Mupicent
Product Name
Mupicent
Registration Number
DRP-6195-05
Brand Name
Mupicent
Generic Name
Mupirocin
Dosage Form
Ointment
Dosage Strength
20 mg/g (2% w/w)
Manufacturer
Scott-Edil Pharmacia Ltd.
Importer
Greencore Pharma Inc
Distributor
Central West Medicale Inc
Issuance Date
27 April 2025
Expiry Date
27 April 2031
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d0c49266ef499f88
Type
Standard
Back to Philippines FDA Approvals